ION-269
/ Ionis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 10, 2025
Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD)
(clinicaltrials.gov)
- P1 | N=1 | Active, not recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Recruiting ➔ Active, not recruiting | N=30 ➔ 1
Enrollment change • Enrollment closed • Alzheimer's Disease • CNS Disorders • Developmental Disorders • Genetic Disorders
1 to 1
Of
1
Go to page
1